跳至主要内容
临床试验/NCT06859723
NCT06859723招募中1 期

High Potency Cannabis: Acute and Protracted Effects

University of California, Los Angeles2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年7月3日最近更新:
干预措施
相关药物

试验速览

阶段
1 期
状态
招募中
入组人数
30
试验地点
2
主要终点
Subject-rated drug effects of abuse liability

研究概览

简要总结

The purpose of this research is to assess the effects of smoked cananbis when cannabis is smoked during periods of cannabis use as usual and after a brief period of abstinence.

详细描述

This outpatient study will assess the acute pharmacodynamic effects of smoked cannabis with ~50 mg and ~100 mg THC compared to placebo (~0 mg THC) and whether a brief period of abstinence alters these effects. Metabolism (pharmacokinetics) of THC will be examined to associate behavioral and physiological effects to plasma concentrations of THC and metabolites.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
21 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • • Male or non-pregnant and non-lactating females aged 21-55 years
  • Report cannabis smoking near daily
  • Not currently seeking treatment for their cannabis use
  • Have a Body Mass Index from 18.5 - 34kg/m
  • Able to perform all study procedures
  • Must be using a contraceptive (hormonal or barrier methods)

排除标准

  • Meeting DSM-V criteria for any substance use disorder other than cannabis, nicotine, caffeine
  • Do not have positive urine toxicology for cannabis use during screening
  • Evidence of severe psychiatric illness (e.g. mood or anxiety disorder with functional impairment or suicide risk, schizophrenia) judged by the study physician (and PI) to put the participant at greater risk of experiencing adverse events due to completion of study procedures, interfere with their ability to participate in the study, or their capacity to provide informed consent.
  • Report using other illicit drugs in the prior 4 weeks
  • Current predominant licit use of medical cannabis, prescription analgesics, or any medications that may affect study outcomes
  • Current pain
  • Pregnancy
  • Currently enrolled in another research protocol
  • Not using a contraceptive method (hormonal or barrier methods)
  • Insensitivity to the cold water stimulus of the Cold Pressor Test
  • Any disorders that might make cannabis administration hazardous as determined by evaluation physician after review of all medical assessments along with medical history.
  • Not able to speak and read English

研究组 & 干预措施

High dose THC

Active Comparator

100 mg THC

干预措施: High dose THC (Drug)

Low dose THC

Active Comparator

50 mg THC

干预措施: Low dose THC (Drug)

Placebo Comparator: Placebo

Placebo Comparator

0 mg THC

干预措施: Placebo Comparator: Placebo (Drug)

结局指标

主要结局

Subject-rated drug effects of abuse liability

时间窗: 3 hours

Subject ratings of "Good Drug Effect" as measured using a visual analog scale (1-100 mm)

Analgesia as measured using the Cold Pressor Test

时间窗: 3 hours

Pain threshold assessed using the Cold Pressor Test (percent baseline)

次要结局

  • Pharmacokinetics of THC and metabolites(3 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ziva D. Cooper, PhD

Professor

University of California, Los Angeles

研究点 (2)

Loading locations...

相似试验